Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Hepatology. 2010 Jan;51(1):121–129. doi: 10.1002/hep.23276

Table 1.

Baseline Characteristics of Participants

Variable (SD) Control (n=10) LS (n=21) P Value
Age (yr) 47.6 (12.0) 48.9 (10.9) 0.78
Sex (M/F) 8/2 14/7 0.68
Weight (kg) 102.9 (20.2) 98.9 (23.9) 0.66
BMI (Kg/m2) 33.7 (4.7) 33.9 (5.3) 0.91
Waist Circumference
(cm)
111.3 (11.2) 109.7 (14.0) 0.74
ALT (U/L) 85.5 (36.5) 85.6 (38.8) 0.99
AST (U/L) 66.0 (46.3) 57.5 (24.9) 0.51
Cholesterol (mg/dL) 235.2 (56.8) 204.8 (50.0) 0.14
LDL (mg/dL) 156.1 (47.7) 126.2 (41.0) 0.10
HDL (mg/dL) 39.9 (9.7) 41.4 (10.2) 0.70
Triglycerides (mg/dL) 208.4 (104.8) 193.1 (120.0) 0.73
Glucose (mg/dL) 152.0 (87.2) 121.1 (28.1) 0.16
HbA1C (%) 6.8 (2.5) 6.3 (0.9) 0.43
Insulin (μU/ml) 20.2 (13.3) 23.7 (12.2) 0.48
HOMA 7.3 (6.2) 7.3 (4.5) 0.99
Metabolic syndrome
(%)
6 (60%) 17 (81%) 0.38
Diabetes (%) 4 (40%) 11 (52%) 0.52
Metformin (%) 3 (30%) 6 (29%) 0.94
TZD (%) 0 2 (10%) 0.82
Insulin (%) 0 1 (5%) 1.00

Data expressed as number (%) or mean (SD)